Authored article by Dr. D. C. Tirupathi Rao, M.D.
Senior Physician & Diabetes Care Physician,
Sugar & Obesity Clinic, Chaitanya Hospital, Karimnagar
KARIMNAGAR, AUGUST 03, 2026: Type 2 diabetes and Obesity are rapidly growing global health concerns. Both conditions significantly increase the risk of severe health complications, including heart disease, stroke, fatty liver, kidney disease, and high blood pressure, said Dr D. C. Tirupathi Rao, M.D., Senior Physician at Chaitanya Hospital, Karimnagar.
He stated that in recent years, drugs known as GLP-1 Receptor Agonists have shown promising results in treating these conditions. Now, Mounjaro, considered an even more effective medication, is gaining worldwide medical attention. With its availability in India, new hope has emerged in the medical field.
What is Mounjaro?
* Active Ingredient: Contains Tirzepatide, developed by the U.S.-based pharmaceutical company Eli Lilly.
* Administration: Given as a weekly subcutaneous injection (under the skin).
* Primary Uses: Used to control Type-2 Diabetes, reduce excess body weight, lower cardiovascular risks, and improve overall quality of life.
How Does Mounjaro Work?
After eating, our body naturally releases two essential gut hormones:
* GLP-1 (Glucagon-Like Peptide-1)
* GIP (Glucose-Dependent Insulinotropic Polypeptide)
The Unique Mechanism of Mounjaro.
Mounjaro simultaneously activates both GLP-1 and GIP receptors. Hence, it is classified as a Dual GIP + GLP-1 Receptor Agonist.
Key Benefits:
* Significantly reduces blood sugar levels.
* Enhances insulin secretion.
* Decreases glucagon production.
* Suppresses appetite and promotes a feeling of fullness even with smaller meals.
* Slows down gastric emptying (stomach clearing).
* Promotes gradual and steady body weight loss.
Who Can Use It? (Under Medical Supervision Only)
* Individuals with Type-2 Diabetes.
* Obese individuals with a BMI of 30 or higher.
* Overweight individuals with a BMI of 27 or higher who also suffer from weight-related complications such as high blood pressure, fatty liver, or sleep apnea.
* Individuals unable to lose weight through lifestyle modifications alone.
Who Should NOT Use It?
* Individuals with Type-1 Diabetes.
* Pregnant women.
* Breastfeeding mothers.
* Patients with a history of severe pancreatitis.
* Individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
* Anyone allergic to Tirzepatide.
Dosage Progression
The dosage of Mounjaro is increased gradually under strict medical guidance:
| Phase | Dose |
|—|—|
| Initial (First 4 Weeks) | 2.5 mg once weekly |
| Weeks 5 to 8 | 5.0 mg once weekly |
| Subsequent Increments (If needed) | 7.5 mg → 10.0 mg → 12.5 mg |
| Maximum Dosage | 15.0 mg once weekly |
> Note: Never alter or increase the dose without consulting your physician.
>
How Much Weight Can You Lose?
* Clinical studies show that patients can experience a 10% to 20% reduction in total body weight.
* Results are optimized when combined with a healthy diet and regular exercise.
* Individual outcomes may vary from person to person.
Impact on Blood Sugar (HbA1c)
Mounjaro effectively leads to:
* A significant reduction in HbA1c levels.
* Lower Fasting Blood Sugar levels.
* Better control of Post-Prandial (Post-Meal) Blood Sugar.
Mounjaro (Tirzepatide) vs. Ozempic (Semaglutide)
| Feature | Mounjaro (Tirzepatide) | Ozempic / Wegovy (Semaglutide) |
|—|—|—|
| Mechanism | Dual GIP + GLP-1 receptor agonist | GLP-1 receptor agonist only |
| Weight Loss Effect | Higher potential weight reduction | Effective weight reduction |
| Glycemic Control | May offer superior blood sugar control | Excellent blood sugar control |
> Which is best? Your doctor will determine the ideal medication based on your specific health profile.
>
Side Effects
Common Side Effects
(Usually temporary and mild during the initial weeks)
* Nausea & Vomiting
* Diarrhea or Constipation
* Abdominal Pain / Gas
* Decreased Appetite
* Fatigue
Severe Side Effects (Requires Immediate Medical Attention)
* Severe abdominal pain / Pancreatitis
* Dehydration
* Severe allergic reactions
* Gallbladder problems
* Potential risks in patients with pre-existing diabetic retinopathy (requires careful monitoring).
Lifestyle Guidelines While on Mounjaro
* Follow a low-calorie, high-protein diet.
* Increase intake of fresh vegetables.
* Engage in 30–45 minutes of daily walking or exercise.
* Stay well-hydrated by drinking sufficient water.
* Ensure adequate and restful sleep.
* Schedule regular HbA1c and health check-ups.
Availability in India
Mounjaro is now available in India. However, pricing, dosage forms, and availability may vary depending on the region. This medication is strictly prescription-only and must be taken under expert clinical supervision.
Important Instructions
* Administer the injection once a week only.
* If a dose is missed, follow your doctor’s guidance on how to resume. Do not self-adjust doses.
* If taking other diabetes drugs or insulin alongside Mounjaro, there is a risk of hypoglycemia (low blood sugar); close monitoring is required.
* Regular follow-up appointments with your physician are mandatory throughout the treatment.
Conclusion
> Mounjaro (Tirzepatide) represents a breakthrough in the management of Type 2 Diabetes and Obesity. Beyond effectively controlling blood sugar, it offers impressive weight management benefits. However, it is not a “magic pill.” The best results are achieved when combined with a balanced diet, regular physical exercise, a healthy lifestyle, and consistent medical oversight.
